Fulminant multifocal relapse in a fingolimod-treated multiple sclerosis patient

ConclusionThis case is unique since this fulminant multifocal relapse occurred in a patient with grade 3 lymphopenia and irreproachable adherence. This observation should be known as a possible side effect of fingolimod treatment.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research